Overcoming the Challenges of Connecting Trial Site Data to Real World Data – The Latest Innovations in Data Connectivity
Connecting real world data to clinical trials holds promise for researchers and patients. It can extend the observation period of studies and supplement data for patients lost to follow up.
Amivantamab compared with real-world therapies in patients with NSCLC with EGFR Exon 20 insertion mutations who have progressed after platinum doublet chemotherapy
Amivantamab is an epidermal growth factor receptor (EGFR)-MET bispecific antibody with immune cell-directing activity.
Datavant Supports FDA Guidance with a Privacy-first Approach to Using Real World Evidence for Regulatory Decision Making
Datavant submitted comments on the recently issued FDA’s guidance that helped to clarify how real world data could be made “fit for purpose” in regulatory decision-making.
Can Connected Health Data Help Close the Gap in U.S. Maternal Mortality Rates?
Today, we are excited to announce the launch of Privacy Hub, one of the core components of Datavant’s Switchboard, which makes it easier for companies to safely connect data. At the same time, we are announcing the acquisition of Mirador Analytics, the leading provider of HIPAA expert determination services and technology.
Optimize Your Decentralized Clinical Trials with Real-World Data
Decentralized clinical trials and real-world data (RWD) are two of the most commonly cited approaches for driving greater efficiency and patient-centricity in clinical research, but can they be brought together to drive even greater impact?